Truvada emtricitabine/tenofovir regulatory update

FDA accepted and granted Priority Review to an sNDA from Gilead for once-daily Truvada emtricitabine/tenofovir for pre-exposure prophylaxis (PrEP) to reduce risk of HIV-1 infection in uninfected adult...